Mycoplasma Testing Market is expected to generate a revenue of USD 1.60 Billion by 2030, Globally, at 8.93% CAGR: Verified Market Research
The mycoplasma testing has the major key driving factor as the increasing prevalence of mycoplasma globally. Along with this, the growing demand for qualitative diagnostic and treatment methods